Application 020254

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001VOLTAREN-XRDICLOFENAC SODIUMTABLET, EXTENDED RELEASE;ORAL100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0781-1381Diclofenac SodiumDiclofenac SodiumSandoz IncNDA AUTHORIZED GENERICCurrent
33358-451Diclofenac SodiumDiclofenac SodiumRxChange Co.NDA AUTHORIZED GENERICCurrent
63187-041Diclofenac SodiumDiclofenac SodiumProficient Rx LPANDACurrent
63629-5096Diclofenac SodiumDiclofenac SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-5096Diclofenac SodiumDiclofenac SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
68788-9389Diclofenac SodiumDiclofenac SodiumPreferred Pharmaceuticals, Inc.NDA AUTHORIZED GENERICCurrent
68788-9389Diclofenac SodiumDiclofenac SodiumPreferred Pharmaceuticals, Inc.NDA AUTHORIZED GENERICCurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
67343SUPPL2021-05-03
67342SUPPL2021-05-03
67253SUPPL2021-04-29
43643SUPPL2016-05-18
24665SUPPL2016-05-12
34438SUPPL2016-05-11
41232SUPPL2015-11-05
34437SUPPL2011-03-04
12376SUPPL2011-03-04
24664SUPPL2011-02-28
2251SUPPL2011-02-28
34436SUPPL2009-03-17
24663SUPPL2009-02-27
2250SUPPL2006-01-30
34435SUPPL2006-01-25